Questions discussed in this category
Will you try the sublingual formulation in a patient who has failed the oral formulation, or vice versa?
Will you recommend this as a first-line agent? Will you use this as monotherapy or only in combination with other agents like duloxetine?
How do you educate patients about the role exercise may play in depression treatment? What type, frequency, and intensity of exercise do you recommend...
What tools do you track to assess progress toward these goals?
When do you consider referral for neurocognitive assessment?
271162709224904271031936025833272522709324166
Papers discussed in this category
Frontiers in medicine, 2023 Apr 25
Arthritis and rheumatism, 1994-01
Pain medicine (Malden, Mass.), 2025 Jul 08
Arthritis care & research, 2023 Jul 04
Annals of medicine, 2011 Jul 19